GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Guardian Pharmacy Services Inc (NYSE:GRDN) » Definitions » Net Change in Cash

GRDN (Guardian Pharmacy Services) Net Change in Cash : $3.1 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Guardian Pharmacy Services Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Guardian Pharmacy Services's Net Change in Cash for the three months ended in Dec. 2024 was $-32.6 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was $3.1 Mil.

Guardian Pharmacy Services Net Change in Cash Historical Data

The historical data trend for Guardian Pharmacy Services's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guardian Pharmacy Services Net Change in Cash Chart

Guardian Pharmacy Services Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Change in Cash
Get a 7-Day Free Trial 6.17 8.56 -14.41 0.15 3.91

Guardian Pharmacy Services Quarterly Data
Dec18 Sep19 Dec19 Mar20 Sep20 Dec20 Mar21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 0.13 - 35.68 -32.56

Guardian Pharmacy Services Net Change in Cash Calculation

Guardian Pharmacy Services's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=57.96+-30.407+-23.645+0
=3.9

Guardian Pharmacy Services's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=22.337+-6.624+-48.274+0
=-32.6

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guardian Pharmacy Services Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Guardian Pharmacy Services's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Guardian Pharmacy Services Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Guardian Pharmacy Services Inc (NYSE:GRDN) » Definitions » Net Change in Cash
Comparable Companies
PACS NHC AGL ASTH ARDT BKD ADUS USPH MD ACHC HCA SAU:4013 XTER:FRE SZSE:300015 XTER:FME XKLS:5225 BSP:RDOR3 BOM:543220 NSE:APOLLOHOSP THC
Traded in Other Exchanges
N/A
Address
300 Galleria Parkway SE, Suite 800, Atlanta, GA, USA, 30339
Website
https://www.guardianpharmacy.com
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.